ADC Therapeutics SA
General ticker "ADCT" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $237.6M
ADC Therapeutics SA does not follow the US Stock Market performance with the rate: -7.4%.
Estimated limits based on current volatility of 6.8%: low 1.79$, high 2.06$
Factors to consider:
- Earnings for 18 months up through Q2 (+1 year) are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2022-12-31 to 2024-12-30
- 2022-12-31 to 2023-12-31 estimated range: [2.29$, 5.85$]
- 2023-12-31 to 2024-12-30 estimated range: [2.19$, 5.35$]
Financial Metrics affecting the ADCT estimates:
- Negative: Non-GAAP EPS, $ of -2.04 <= 0.10
- Negative: Operating profit margin, % of -37.07 <= 1.03
- Negative: negative Net income
- Negative: Operating cash flow per share per price, % of -34.75 <= 2.35
- Negative: Industry operating profit margin (median), % of -98.17 <= 2.14
- Positive: Inventory ratio change, % of -9.72 <= -1.03
Short-term ADCT quotes
Long-term ADCT plot with estimates
Financial data
| YTD | 2020-12-31 | 2021-12-31 | 2022-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $33.92MM | $209.91MM |
| Operating Expenses | $219.26MM | $295.64MM | $333.54MM |
| Operating Income | $-219.26MM | $-261.72MM | $-123.63MM |
| Non-Operating Income | $-26.70MM | $10.21MM | $-31.03MM |
| Interest Expense | $4.93MM | $18.34MM | $36.92MM |
| R&D Expense | $142.03MM | $158.00MM | $187.90MM |
| Income(Loss) | $-245.96MM | $-251.50MM | $-154.66MM |
| Taxes | $0.33MM | $-21.48MM | $1.14MM |
| Profit(Loss) | $-246.29MM | $-230.03MM | $-155.80MM |
| Stockholders Equity | $335.50MM | $166.09MM | $88.73MM |
| Inventory | $6.50MM | $11.12MM | $18.56MM |
| Assets | $513.69MM | $617.97MM | $529.17MM |
| Operating Cash Flow | $-168.73MM | $-233.38MM | $-136.79MM |
| Capital expenditure | $2.81MM | $6.38MM | $2.30MM |
| Investing Cash Flow | $-2.83MM | $-6.67MM | $-2.51MM |
| Financing Cash Flow | $494.97MM | $267.39MM | $-0.59MM |
| Earnings Per Share* | $-3.77 | $-3.00 | $-1.99 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.